Kidney disease and electrolytes in COVID-19: more than meets the eye.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

1. Investigation of renal function in patients with long COVID in the Amazon region: a cross-sectional study.BMC infectious diseases · 2025
   Observational
2. Proximal tubular dysfunction as a predictor of AKI in Hospitalized COVID-19 patients.PloS one · 2024
   Observational
3. A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.Open medicine (Warsaw, Poland) · 2024
   Review
4. SCARF Genes in COVID-19 and Kidney Disease: A Path to Comorbidity-Specific Therapies.International journal of molecular sciences · 2023
   Review
5. Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice.Communications biology · 2023
   Article
6. The measurement of basal creatinine and the diagnosis of AKI with COVID-19.International urology and nephrology · 2023
   Article
7. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia · 2022
   Review
8. Potential Association of Hypernatremia With Mortality in Patients With Acute Kidney Injury and COVID-19.Cureus · 2022
   Article
9. Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients.International urology and nephrology · 2022
   Review
10. Should we continue to use renin-angiotensin-aldosterone system blockers in patients with COVID-19?Clinical kidney journal · 2022
    Article
11. Acute kidney injury in hospitalized COVID-19 patients.International urology and nephrology · 2022
    Article
12. Post-acute COVID-19 syndrome and kidney diseases: what do we know?Journal of nephrology · 2022
    Review
13. Differential Diagnostic Challenges in the COVID-19 Pandemic: Renal Abscess After SARS-CoV-2 Infection in a Young Adolescent.The American journal of case reports · 2022
    Article
14. More on the invisibility of chronic kidney disease… and counting.Clinical kidney journal · 2022
    Article
15. Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy.Nitric oxide : biology and chemistry · 2022
    Review
16. Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study.Clinical kidney journal · 2022
    Article
17. Impact of COVID-19 on Renal Function: A Multivariate Analysis of Biochemical and Immunological Markers in Patients.Cureus · 2022
    Article
18. The Association of New-Onset Acute Kidney Injury and Mortality in Critically Ill Patients With COVID-19 With Less Severe Clinical Conditions at Admission: A Moderation Analysis.Frontiers in medicine · 2022
    Article
19. Racial differences in cardiopulmonary outcomes of hospitalized COVID-19 patients with acute kidney injury.Reviews in cardiovascular medicine · 2021
    Article
20. Mesenchymal stem cells and COVID-19: What they do and what they can do.World journal of stem cells · 2021
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as